Reported revenues of $5.7 million in 4Q23, up 77% over prior year
Full year revenues of $18.5 million, up 49% over prior year
Gross Margin of 90% in 4Q23 and 86% for full year
CMS.
By Ben Glickman Shares of TriSalus Life Sciences jumped after the company announced the Centers for Medicare & Medicaid Services has created a new code.